Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
Key Highlights
- ➤ELMNT IR ordered up to a 12-month supply of LIBERTY devices
- ➤ELMNT IR became LIBERTY’s first OBL customer worldwide
- ➤Microbot gained its first LIBERTY customer on the West Coast
- ➤Jonathan Steinberger completed multiple LIBERTY procedures, including Y90 mapping
- ➤Microbot said ELMNT IR placed advance orders for additional LIBERTY systems
Expert Statements
Jonathan Steinberger, M.D., Co-founder and Interventional Radiologist at ELMNT IR
“Having used LIBERTY for multiple procedures, I’ve found that the combination of a compact footprint, efficient workflow, and the elimination of upfront capital costs and expenses associated with traditional equipment makes LIBERTY an optimal system for establishing an Endovascular Robotic Program in an OBL”
Jonathan Steinberger, M.D., Co-founder and Interventional Radiologist at ELMNT IR
“We have seen firsthand the value it can bring to physicians and patients. Based on our experience to date, LIBERTY is well positioned to become a standard for the use of robotics in endovascular intervention procedures.”
Harel Gadot, Chairman, CEO, President of Microbot Medical
“This is a significant milestone for us, and we believe it supports the value that LIBERTY brings across multiple sites of care settings, especially in OBLs, as we believe they are an important and growing segment of the market”
Harel Gadot, Chairman, CEO, President of Microbot Medical
“Our relationship with ELMNT IR, which has already resulted in advance orders of the LIBERTY System from ELMNT IR, continues a trend in which every customer that has utilized its initial LIBERTY inventory has subsequently reordered additional systems.”
Harel Gadot, Chairman, CEO, President of Microbot Medical
“We believe this reflects high satisfaction among physicians, as well as the acceptance by hospital administration, as they recognize the value of the system.”
Harel Gadot, Chairman, CEO, President of Microbot Medical
“Furthermore, in addition to expanding access to healthcare networks, this represents an additional revenue opportunity for the LIBERTY System as we expect the number of peripheral vascular interventions performed in OBLs to continue to increase.”
ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company’s Full Market Release strategy.
The Company believes the OBLs represent a rapidly growing healthcare segment and opportunity as many endovascular procedures are being done outside traditional hospital settings and Ambulatory Surgery Centers.
Get started
Create a free account to read the full story.